Cargando…
Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum]
Autores principales: | Kameoka, Y, F, Kishi, M, Koura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535426/ https://www.ncbi.nlm.nih.gov/pubmed/31190747 http://dx.doi.org/10.2147/DDDT.S212028 |
Ejemplares similares
-
Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis
por: Kameoka, Yosuke, et al.
Publicado: (2019) -
Corrigendum to “Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy”
por: Moastafa, Tarek M., et al.
Publicado: (2015) -
Corrigendum to “Pericardial Tamponade: An Uncommon Clinical Presentation in cANCA Related Vasculitis and Glomerulonephritis in Association with Very High Titres of ANA”
por: Vanga, Amaresh, et al.
Publicado: (2019) -
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum]
Publicado: (2017) -
lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells [Corrigendum]
Publicado: (2020)